Back to Home

Healthcare Affordability

Expert articles and analysis related to healthcare affordability.

197 articles•Last 30 Days

AI Summary — Last 30 Days

CMS is accelerating affordability-focused payment reform under the Trump administration, pairing evidence from the Comprehensive Care for Joint Replacement model—reported to have generated $180M in Medicare savings while maintaining quality—with signals that episode-based models could expand nationally, reinforcing downside-risk readiness for hospitals, specialists, and ACO-adjacent networks. At the same time, CMS finalized the GLOBE drug pricing model to apply most-favored-nation-style pricing to Part B drugs, triggering immediate pharma litigation and sharpening the strategic tension between federal savings targets, provider drug-margin exposure, and specialty-care access. Medicare Advantage remains under cost and quality scrutiny, with 2027 Star Ratings supporting bonus payments for high-rated plans even as MedPAC’s $76B overpayment estimate and county-level plan exits raise pressure on payers and risk-bearing providers to prove value through coding integrity, network performance, and benefit sustainability. CJR savings and expansion implications GLOBE drug pricing model litigation

Related Articles

98ALN

Op-ed: Our healthcare affordability crisis is a structural problem. We need structural solutions

Op-ed: Our healthcare affordability crisis is a structural problem. We need structural solutions  Fierce Healthcare

Fierce HealthcareSep 11, 2026
95ALN

The US experiments with international reference pricing for prescription drugs

The US experiments with international reference pricing for prescription drugs  The Lancet

The LancetSep 14, 2026
95ALN

Most-favoured-nation pricing for prescription drugs in US Medicare: a cohort study

Most-favoured-nation pricing for prescription drugs in US Medicare: a cohort study  The Lancet

The LancetSep 13, 2026
95ALN

STAT+: Trump’s secretive pharma deals may undermine ‘most-favored nation’ pricing, an analysis suggests

The projected savings from Trump's "most-favored nation" pricing policy might be drastically reduced by secretive deals with pharma companies, a new analysis finds.

STAT NewsSep 13, 2026
95ALN

Scotland County Hospital joins Show-Me High Value Network - hannibal.net

Scotland County Hospital joins Show-Me High Value Network  hannibal.net

news.google.comSep 12, 2026
95ALN

Employer, consumer groups urge lawmakers to reform No Surprises Act's IDR

Employer, consumer groups urge lawmakers to reform No Surprises Act's IDR  Fierce Healthcare

Fierce HealthcareSep 11, 2026
95ALN

Health spending tied to rise in premiums, new study finds

The study, published last week in JAMA, counters concerns that insurers are raising premiums to pad profits.

Healthcare DiveSep 11, 2026
95ALN

Indiana Sets Hard Price Ceiling For Large Non-Profit Hospital Systems - open minds

Indiana Sets Hard Price Ceiling For Large Non-Profit Hospital Systems  open minds

Open MindsSep 11, 2026
92ALN

Drug Channels: Average Manufacturer Price (AMP)

AMP - Drug Channels  Drug Channels

Drug ChannelsSep 13, 2026
90ALN

MFN Drug Agreements Could Raise Prices Worldwide

AJMCSep 13, 2026